論文 - 詳細
| RRC ID | 65673 |
|---|---|
| 著者 | Nagasaki K, Nakashima A, Tamura R, Ishiuchi N, Honda K, Ueno T, Doi S, Kato Y, Masaki T. |
| タイトル | Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis. |
| ジャーナル | Stem Cell Res Ther |
| Abstract |
BACKGROUND:Mesenchymal stem cells (MSCs) provide potential treatments for peritoneal fibrosis. However, MSCs cultured in media containing serum bring risks of infection and other problems. In this study, we compared the effect of human MSCs in serum-free medium (SF-MSCs) on peritoneal fibrosis with that of MSCs cultured in medium containing 10% fetal bovine serum (10%MSCs). METHODS:Peritoneal fibrosis was induced by intraperitoneally injecting 0.1% chlorhexidine gluconate (CG). SF-MSCs or 10%MSCs were intraperitoneally administered 30 min after the CG injection. Ten days after the CG and MSC injections, we performed histological analyses and peritoneal equilibrium testing. In the in vitro experiments, we used transforming growth factor (TGF)-β1-stimulated human peritoneal mesothelial cells incubated in conditioned medium from MSCs to examine whether the SF-MSCs showed enhanced ability to produce antifibrotic humoral factors. RESULTS:Histological staining showed that the SF-MSCs significantly suppressed CG-induced cell accumulation and thickening compared with that of the 10%MSCs. Additionally, the SF-MSCs significantly inhibited mesenchymal cell expression, extracellular matrix protein deposition and inflammatory cell infiltration. Peritoneal equilibration testing showed that compared with administering 10%MSCs, administering SF-MSCs significantly reduced the functional impairments of the peritoneal membrane. The in vitro experiments showed that although the conditioned medium from MSCs suppressed TGF-β1 signaling, the suppression did not significantly differ between the SF-MSCs and 10%MSCs. CONCLUSIONS:Serum-free culture conditions can enhance the antifibrotic abilities of MSCs by suppressing inflammation. Administering ex vivo expanded SF-MSCs may be a potential therapy for preventing peritoneal fibrotic progression. |
| 巻・号 | 12(1) |
| ページ | 203 |
| 公開日 | 2021-3-23 |
| DOI | 10.1186/s13287-021-02273-1 |
| PII | 10.1186/s13287-021-02273-1 |
| PMID | 33757592 |
| PMC | PMC7986267 |
| MeSH | Cells, Cultured Culture Media, Conditioned / pharmacology Humans Mesenchymal Stem Cells* Peritoneal Fibrosis* / chemically induced Peritoneal Fibrosis* / genetics Peritoneal Fibrosis* / therapy Peritoneum Serum |
| IF | 5.116 |
| リソース情報 | |
| ヒト・動物細胞 | Human mesenchymal stem cells |